Yuhan, ViroMed Agree on Joint Research Collaboration

Published: 2004-12-22 06:58:00

Updated: 2004-12-22 06:58:00

Yuhan Corporation, one of leading domestic pharmaceutical manufacturers, recently made a joint research collaboration agreement with ViroMed Co., a local biotech venture company recognized for its active research and development efforts on gene-based medical and pharmaceutical therapies.

Base...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK